Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Status:
NOT_YET_RECRUITING
Trial end date:
2028-03-15
Target enrollment:
Participant gender:
Summary
To evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.
Phase:
PHASE2
Details
Lead Sponsor:
HIV Prevention Trials Network
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)